GGrantIndex
Sort

17,054 grants matching genome editing

Genome Editing and Animal Models Shared Resource

$71,657
Christopher A Bradfield · University Of Wisconsin-Madison · P30 · FY2021 · CA

CRISPR tools to dissect the coding and non-coding genome

$71,636
Joana Vidigal · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Role of Dopamine Neuron-Specific Gene Enhancers in Cocaine Relapse

$71,635
Luis Miguel Tuesta · Boston Children'S Hospital · K01 · FY2018 · DA

Engineering platforms for genome-scale screening of transcriptional activation domains

$71,587
Pablo Perez-Pinera · University Of Illinois At Urbana-Champaign · R03 · FY2019 · EB

cGAS-mediated glial responses to DNA damage: A pilot study

$71,428
Christine A Richardson · University Of North Carolina Charlotte · R03 · FY2019 · NS

Hereditary Cancer Variants of Uncertain Significance in Stem Cells

$71,425
Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2020 · CA

Hematologic Malignancies

$71,402
Thomas J. Kipps · University Of California, San Diego · P30 · FY2020 · CA

cGAS-mediated glial responses to DNA damage: A pilot study

$71,204
Christine A Richardson · University Of North Carolina Charlotte · R03 · FY2020 · NS

Deciphering the mechanism of SHIP1 regulation in human neutrophils

$71,049
Scott David Hansen · University Of Oregon · R01 · FY2024 · GM

The Function of Small RNA-Based viral Defense System in E. coli

$71,040
Konstantin V Severinov · Rutgers, The State Univ Of N.J. · R01 · FY2021 · GM

Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems

$70,990
Rakhi Rajan · University Of Oklahoma · R03 · FY2024 · AI

Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems

$70,990
Rakhi Rajan · University Of Oklahoma · R03 · FY2025 · AI

Novel Genome Editing for the Treatment of Glaucoma

$70,857
Val C Sheffield · University Of Iowa · R01 · FY2020 · EY

Prime editing for Crumbs homologue 1 (CRB1) Inherited Retinal Dystrophies

$70,723
Peter Martin John Quinn · Columbia University Health Sciences · R01 · FY2024 · EY

Mechanisms of CRISPR-mediated immunity and applications beyond editing

$70,625
Andrew Santiago-Frangos · Montana State University - Bozeman · K99 · FY2023 · GM

A Novel Role for Phospholamban in the Thalamic Reticular Nucleus

$70,504
Pothitos Pitychoutis · University Of Dayton · R03 · FY2018 · NS

Diversity supplement to P01CA240685 to characterize bromodomain proteins associated with endocrine therapy resistance in breast cancer

$70,497
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2024 · CA

Design and Development of Ligand-ResponsiveCRISPR-Cas Enzymes

$70,458
Brady Fletcher Cress · University Of California Berkeley · F32 · FY2021 · GM

A systems approach to understanding overall drug response in a heterogeneous tumor-cell population

$70,458
James Hyun-Woo Park · Institute For Systems Biology · F32 · FY2021 · CA

Human induced pluripotent stem cell modeling of genetic risk factors for Alzheimer's disease

$70,458
Michael D Gallagher · Whitehead Institute For Biomedical Res · F32 · FY2021 · AG

Transcriptional regulation of neural circuit formation in intellectual disabilities

$70,458
Carlos Antonio Diaz-Balzac · University Of Rochester · F32 · FY2021 · HD

Genetic Variants Associated with Alzheimer's disease and Related Dementias

$70,373
Mark Cookson · National Institute On Aging · ZIA · FY2022 · AG

Diversity Supplement R01----Mdm2 Alternative Splicing in DNA Damage and Cancer

$70,289
Dawn S Chandler · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · CA

MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma

$70,274
Yong Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA

Charcot-Marie-Tooth (CMT) Disease

$70,235
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR